• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双链DNA自身抗体在系统性红斑狼疮患者的诊断、分类及随访中的应用

Autoantibodies to dsDNA in the diagnosis, classification and follow-up of patients with systemic lupus erythematosus.

作者信息

Damoiseaux Jan, van Beers Joyce

机构信息

Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, the Netherlands.

出版信息

J Transl Autoimmun. 2023 Jan 21;6:100191. doi: 10.1016/j.jtauto.2023.100191. eCollection 2023.

DOI:10.1016/j.jtauto.2023.100191
PMID:36718274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9883238/
Abstract

Autoantibodies, in particular anti-dsDNA antibodies, are increasingly used for diagnosis, classification and follow-up of patients with SLE. Since standardization of autoantibody assays is a major challenge, more attention should be paid to harmonization initiatives and better definition of required test characteristics in classification criteria. For diagnosis and follow-up separate multi-center studies are required to establish test characteristics of distinct immuno-assays for both purposes. Finally, such studies should consider not to evaluate SLE as a single disease, but as a disease with distinct subtypes.

摘要

自身抗体,尤其是抗双链DNA抗体,越来越多地用于系统性红斑狼疮(SLE)患者的诊断、分类和随访。由于自身抗体检测的标准化是一项重大挑战,因此应更加关注协调举措,并在分类标准中更好地定义所需的检测特征。为了进行诊断和随访,需要开展单独的多中心研究,以确定用于这两个目的的不同免疫检测的检测特征。最后,此类研究应考虑不要将SLE视为单一疾病,而是视为具有不同亚型的疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad6/9883238/314f6ed4f3f8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad6/9883238/f17e55680594/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad6/9883238/314f6ed4f3f8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad6/9883238/f17e55680594/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad6/9883238/314f6ed4f3f8/gr2.jpg

相似文献

1
Autoantibodies to dsDNA in the diagnosis, classification and follow-up of patients with systemic lupus erythematosus.双链DNA自身抗体在系统性红斑狼疮患者的诊断、分类及随访中的应用
J Transl Autoimmun. 2023 Jan 21;6:100191. doi: 10.1016/j.jtauto.2023.100191. eCollection 2023.
2
Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus.系统性红斑狼疮分类标准中的抗双链DNA抗体
J Transl Autoimmun. 2021 Dec 28;5:100139. doi: 10.1016/j.jtauto.2021.100139. eCollection 2022.
3
Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.多种自身抗体检测方法在系统性红斑狼疮中的比较。
J Immunol Methods. 2010 Jun 30;358(1-2):75-80. doi: 10.1016/j.jim.2010.04.005. Epub 2010 May 9.
4
Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.使用多重检测方法测量系统性红斑狼疮患者的自身抗体。
J Immunol Methods. 2010 Jan 31;352(1-2):147-52. doi: 10.1016/j.jim.2009.10.003. Epub 2009 Oct 20.
5
Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.中性粒细胞胞外诱捕网线粒体 DNA 及其自身抗体在系统性红斑狼疮中的作用及二甲双胍的概念验证试验。
Arthritis Rheumatol. 2015 Dec;67(12):3190-200. doi: 10.1002/art.39296.
6
Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.抗双链 DNA、抗核小体、抗 C1q 和抗组蛋白抗体作为活动性狼疮肾炎和系统性红斑狼疮疾病活动的标志物。
Immun Inflamm Dis. 2021 Jun;9(2):407-418. doi: 10.1002/iid3.401. Epub 2021 Jan 20.
7
Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.不同的清除机制、中性粒细胞胞外诱捕网降解和吞噬作用,在具有不同自身抗体特异性的系统性红斑狼疮患者中发挥作用。
Immunol Lett. 2015 Dec;168(2):254-9. doi: 10.1016/j.imlet.2015.09.016. Epub 2015 Oct 3.
8
Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.儿童起病系统性红斑狼疮中自身抗体的检测及其与疾病相关表现的关系。
Semin Arthritis Rheum. 2012 Jun;41(6):840-8. doi: 10.1016/j.semarthrit.2011.09.009. Epub 2011 Dec 15.
9
RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.RNA测序分析揭示了具有不同自身抗体特异性的系统性红斑狼疮患者独特的转录组特征。
PLoS One. 2016 Nov 11;11(11):e0166312. doi: 10.1371/journal.pone.0166312. eCollection 2016.
10
Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.系统性红斑狼疮患者存在独特的自身抗体谱,与 TLR7 和 TLR9 的上调呈选择性相关。
J Clin Immunol. 2013 Jul;33(5):954-64. doi: 10.1007/s10875-013-9887-0. Epub 2013 Apr 7.

引用本文的文献

1
Glycosylation of anti-dsDNA IgG correlates with organ involvement in treatment-naïve patients with systemic lupus erythematosus.抗双链DNA IgG的糖基化与初治系统性红斑狼疮患者的器官受累情况相关。
Lupus Sci Med. 2025 Sep 1;12(2):e001665. doi: 10.1136/lupus-2025-001665.
2
Mechanistic Evaluation of Anti-CD19 CAR-T Cell Therapy Repurposed in Systemic Lupus Erythematosus Using a Quantitative Systems Pharmacology Model.使用定量系统药理学模型对系统性红斑狼疮中重新利用的抗CD19 CAR-T细胞疗法进行机制评估。
Clin Transl Sci. 2025 Feb;18(2):e70146. doi: 10.1111/cts.70146.
3
Lupus Nephritis Risk Factors and Biomarkers: An Update.

本文引用的文献

1
SLE classification criteria: Science-based icons or algorithmic distractions - an intellectually demanding dilemma.SLE 分类标准:基于科学的图标还是算法干扰 - 一个高智力要求的困境。
Front Immunol. 2022 Sep 28;13:1011591. doi: 10.3389/fimmu.2022.1011591. eCollection 2022.
2
Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases.抗核抗体(ANA)作为系统性自身免疫性疾病分类和诊断的一项标准。
J Transl Autoimmun. 2022 Jan 19;5:100145. doi: 10.1016/j.jtauto.2022.100145. eCollection 2022.
3
Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus.
狼疮性肾炎的危险因素和生物标志物:研究进展。
Int J Mol Sci. 2023 Sep 25;24(19):14526. doi: 10.3390/ijms241914526.
系统性红斑狼疮分类标准中的抗双链DNA抗体
J Transl Autoimmun. 2021 Dec 28;5:100139. doi: 10.1016/j.jtauto.2021.100139. eCollection 2022.
4
Laboratory evaluation of anti-dsDNA antibodies.抗 dsDNA 抗体的实验室评估。
Clin Chim Acta. 2022 Mar 1;528:34-43. doi: 10.1016/j.cca.2021.12.029. Epub 2022 Jan 10.
5
Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review.抗双链 DNA 检测对系统性红斑狼疮的特异性:系统评价。
J Appl Lab Med. 2022 Jan 5;7(1):221-239. doi: 10.1093/jalm/jfab146.
6
ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization.抗中性粒细胞胞浆抗体检测在临床实践中的应用:从实施到质量控制与协调。
Front Immunol. 2021 Mar 16;12:656796. doi: 10.3389/fimmu.2021.656796. eCollection 2021.
7
Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper.通过报告特定检测结果似然比实现抗中性粒细胞胞浆抗体(ANCA)检测的标准化:立场文件
Clin Chem Lab Med. 2020 Oct 16;59(2):e35-e39. doi: 10.1515/cclm-2020-1178.
8
The perspective on standardisation and harmonisation: the viewpoint of the EASI president.标准化与协调统一的观点:欧洲麻醉与重症监护学会主席的观点
Auto Immun Highlights. 2020 Feb 6;11(1):4. doi: 10.1186/s13317-020-0127-3.
9
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.2019 年欧洲抗风湿病联盟/美国风湿病学会系统性红斑狼疮分类标准。
Ann Rheum Dis. 2019 Sep;78(9):1151-1159. doi: 10.1136/annrheumdis-2018-214819. Epub 2019 Aug 5.
10
The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination.抗双链DNA抗体的临床应用及其检测面临的挑战。
J Immunol Methods. 2018 Aug;459:11-19. doi: 10.1016/j.jim.2018.05.014. Epub 2018 May 26.